...
首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Virtual screening for Raf-1 kinase inhibitors based on pharmacophore model of substituted ureas.
【24h】

Virtual screening for Raf-1 kinase inhibitors based on pharmacophore model of substituted ureas.

机译:基于取代脲的药效团模型对Raf-1激酶抑制剂进行虚拟筛选。

获取原文
获取原文并翻译 | 示例
           

摘要

A three-dimensional (3D) quantitative pharmacophore model was developed from a training set of structurally diverse substituted ureas against Raf-1 kinase, which was well validated to be highly predictive by two methods, namely, test set prediction and Cat-Scramble method. Then a virtual database searching was performed with the pharmacophore model as a 3D query, and the bioactivities of the retrieved hits were predicted by the pharmacophore. Subsequently, molecular docking was carried out on the selected hits whose estimated IC(50) was less than 1 microM. Finally, 29 hits were identified as potential leads against Raf-1 kinase, which exhibited good estimated activities, high docking scores, similar binding mode to experimentally proven compounds and favorable drug-like properties. The study may facilitate the discovery and rational design of novel leads with potent inhibitory activity targeting Raf-1 kinase.
机译:从针对Raf-1激酶的结构多样的取代尿素训练集建立了三维(3D)定量药效团模型,该模型已通过测试集预测和Cat-Scramble方法两种方法很好地验证了其高预测性。然后,以药效团模型作为3D查询执行虚拟数据库搜索,并通过药效团预测检索到的命中的生物活性。随后,对估计的IC(50)小于1 microM的选定命中分子进行了分子对接。最终,鉴定出29个命中点是对抗Raf-1激酶的潜在先导,该Raf-1激酶表现出良好的估计活性,高对接得分,与实验证明的化合物相似的结合模式以及良好的类药物特性。这项研究可能有助于发现和合理设计具有针对Raf-1激酶的强抑制活性的新线索。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号